LifeVantage (NASDAQ:LFVN) Receives New Coverage from Analysts at StockNews.com

Posted by on Jun 18th, 2023

Stock analysts at StockNews.com began coverage on shares of LifeVantage (NASDAQ:LFVN – Get Rating) in a report issued on Sunday. The firm set a “strong-buy” rating on the stock.

LifeVantage Stock Performance

Shares of LFVN stock opened at $5.15 on Friday. The stock has a market capitalization of $65.89 million, a P/E ratio of -85.83 and a beta of 1.05. The company has a 50 day moving average price of $4.11 and a 200 day moving average price of $3.88. LifeVantage has a fifty-two week low of $3.04 and a fifty-two week high of $5.74.

LifeVantage (NASDAQ:LFVN – Get Rating) last announced its quarterly earnings data on Thursday, May 4th. The company reported $0.08 earnings per share for the quarter. The firm had revenue of $53.74 million during the quarter. LifeVantage had a negative net margin of 0.40% and a positive return on equity of 3.32%. On average, research analysts forecast that LifeVantage will post 0.23 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. EP Wealth Advisors LLC purchased a new position in LifeVantage in the first quarter worth approximately $574,000. Susquehanna International Group LLP lifted its stake in LifeVantage by 23.3% in the first quarter. Susquehanna International Group LLP now owns 30,747 shares of the company’s stock worth $110,000 after acquiring an additional 5,802 shares during the last quarter. Tower Research Capital LLC TRC lifted its stake in LifeVantage by 117.5% in the third quarter. Tower Research Capital LLC TRC now owns 11,362 shares of the company’s stock worth $42,000 after acquiring an additional 6,138 shares during the last quarter. Renaissance Technologies LLC lifted its position in shares of LifeVantage by 0.3% during the 2nd quarter. Renaissance Technologies LLC now owns 974,318 shares of the company’s stock worth $4,238,000 after buying an additional 3,300 shares during the last quarter. Finally, State Street Corp lifted its position in shares of LifeVantage by 7.6% during the 1st quarter. State Street Corp now owns 46,191 shares of the company’s stock worth $220,000 after buying an additional 3,281 shares during the last quarter. Hedge funds and other institutional investors own 29.69% of the company’s stock.

LifeVantage Company Profile

(Get Rating)

LifeVantage Corp. engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and personal care products. The firm operates through the following geographical segments: Americas Region, and Asia/Pacific and Europe Region. Its products include Protandim, LifeVantage Omega+ and ProBio, TrueScience and Petandim for dogs.

Featured Articles

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.